Cell-free DNA copy number variations predict efficacy of immune checkpoint inhibitor-based therapy in hepatobiliary cancers [PDF]
Background This study was designed to screen potential biomarkers in plasma cell-free DNA (cfDNA) for predicting the clinical outcome of immune checkpoint inhibitor (ICI)-based therapy in advanced hepatobiliary cancers.Methods Three cohorts including 187
Ying Hu +19 more
doaj +2 more sources
Cell-free DNA test for pathogenic copy number variations: A retrospective study
Objective: To evaluate the detection rate (DR) by prenatal cell-free DNA test for pathogenic copy number variations (CNVs)>2 Mb among pregnancies with fetal ultrasound abnormalities.
Hong-Lei Duan +7 more
doaj +3 more sources
DNA copy number variations in children with vesicoureteral reflux and urinary tract infections. [PDF]
Vesicoureteral reflux (VUR) is a complex, heritable disorder. Genome-wide linkage analyses of families affected by VUR have revealed multiple genomic loci linked to VUR.
Dong Liang +9 more
doaj +2 more sources
DNA copy number variations and craniofacial abnormalities in 1,457 children with neurodevelopmental disorders [PDF]
Background This study aimed to investigate deoxyribonucleic acid (DNA) copy number variations (CNVs) in children with neurodevelopmental disorders and their association with craniofacial abnormalities.
Dandan Wu +9 more
doaj +2 more sources
Association of Mitochondrial DNA Copy Number Variations with Triple-Negative Breast Cancer: A Potential Biomarker Study [PDF]
Background/Objectives: Triple-negative breast cancer (TNBC) is a highly aggressive subtype with limited therapeutic options, and identifying reliable biomarkers for diagnosis and prognosis is crucial for improving patient outcomes.
Karin Manto +8 more
doaj +2 more sources
Objective: To evaluate the accuracy of expanded noninvasive prenatal testing (NIPT) for maternal copy number variations. Materials and methods: Expanded NIPT was used to detect CNVs ≥2 Mb at a whole-genome scale.
Honglei Duan +5 more
doaj +3 more sources
Genomic characterization of ER-positive primary tumors and corresponding relapses identifies potentially targetable alterations [PDF]
The majority of breast cancer patients have tumors expressing estrogen receptor α (ER) and receive endocrine therapy. However, around one-third relapse in their disease, predominantly with retained ER expression.
Caroline Schagerholm Stanev +5 more
doaj +2 more sources
Perspective: DNA Copy Number Variations in Cardiovascular Diseases [PDF]
Iti Garg, Mohammad Zahid Ashraf
exaly +2 more sources
DNA Copy Number Variations as Markers of Mutagenic Impact [PDF]
Tigran Harutyunyan +2 more
exaly +2 more sources
Cell‐free DNA copy number variations in plasma from colorectal cancer patients [PDF]
Liang Wang, Jian Li, Meijun Du
exaly +2 more sources

